BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1504150)

  • 1. Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia.
    Vadhan-Raj S
    Immunol Ser; 1992; 57():661-70. PubMed ID: 1504150
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
    Sakamoto KM; Gasson JC
    Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 4. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
    Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM
    Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of colony stimulating factors in the treatment of aplastic anemia].
    Domingo Morera JM; Palomera Bernal L; Agulló Alcober JA; Olave Rubio MT
    Med Clin (Barc); 1994 Dec; 103(20):799. PubMed ID: 7532252
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
    Bezwoda WR; Dajee D
    Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.
    Jaime-Pérez JC; González-Llano O; Gómez-Almaguer D
    Am J Hematol; 2001 Jan; 66(1):71. PubMed ID: 11426504
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of granulocyte-macrophage colony stimulating factor on paroxysmal nocturnal hemoglobinuria: a case report.
    Webb DI; Bundtzen JL
    Alaska Med; 1993; 35(3):216-7, 224. PubMed ID: 8109693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic value of interleukin-3 given alone or in combination with other cytokines.
    Ganser A; Hoelzer D
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):245-6. PubMed ID: 8337137
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of hematopoietic growth factors].
    Krusius T
    Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
    [No Abstract]   [Full Text] [Related]  

  • 15. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.
    Lopez KD; Guinan EC
    Pediatr Nurs; 1995; 21(4):345-9. PubMed ID: 7644282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Gratwohl A; Dazzi H; Tichelli A; Stebler C; Wernli M; Thomssen C; Kim I; Dieterle A; Obrist R; Stern A
    Schweiz Med Wochenschr; 1991 Mar; 121(12):413-7. PubMed ID: 2028244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the research of clinical use of recombinant human granulocyte colony-stimulating factors].
    Jiang FG; Geng JP; Yang CL
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):723-5. PubMed ID: 1726145
    [No Abstract]   [Full Text] [Related]  

  • 18. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of granulocyte colony-stimulating factor for treatment of aplastic anemia.
    Kojima S
    Nagoya J Med Sci; 1999 Nov; 62(3-4):77-82. PubMed ID: 10689869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.